How big is the Macular Degeneration Treatment Market?

The Macular Degeneration Treatment Market size is expected to reach USD 15.47 billion in 2024 and grow at a CAGR of 8.51% to reach USD 23.29 billion by 2029. Read More

What is the current Macular Degeneration Treatment Market size?

In 2024, the Macular Degeneration Treatment Market size is expected to reach USD 15.47 billion. Read More

Who are the key players in Macular Degeneration Treatment Market?

Novartis AG, Bausch Health Companies Inc., REGENXBIO Inc., F Hoffmann-La Roche Ltd and Regeneron Pharmaceuticals Inc. are the major companies operating in the Macular Degeneration Treatment Market. Read More

Which is the fastest growing region in Macular Degeneration Treatment Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Macular Degeneration Treatment Market?

In 2024, the North America accounts for the largest market share in Macular Degeneration Treatment Market. Read More

What years does this Macular Degeneration Treatment Market cover, and what was the market size in 2023?

In 2023, the Macular Degeneration Treatment Market size was estimated at USD 14.26 billion. The report covers the Macular Degeneration Treatment Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Macular Degeneration Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Macular Degeneration Treatment Companies

This report lists the top Macular Degeneration Treatment companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Macular Degeneration Treatment industry.